235 related articles for article (PubMed ID: 37720315)
1. Effect of pro-inflammatory cytokine priming and storage temperature of the mesenchymal stromal cell (MSC) secretome on equine articular chondrocytes.
Jammes M; Contentin R; Audigié F; Cassé F; Galéra P
Front Bioeng Biotechnol; 2023; 11():1204737. PubMed ID: 37720315
[No Abstract] [Full Text] [Related]
2. Pro-Inflammatory Cytokine Priming and Purification Method Modulate the Impact of Exosomes Derived from Equine Bone Marrow Mesenchymal Stromal Cells on Equine Articular Chondrocytes.
Jammes M; Cassé F; Velot E; Bianchi A; Audigié F; Contentin R; Galéra P
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762473
[TBL] [Abstract][Full Text] [Related]
3. Bone Marrow MSC Secretome Increases Equine Articular Chondrocyte Collagen Accumulation and Their Migratory Capacities.
Contentin R; Jammes M; Bourdon B; Cassé F; Bianchi A; Audigié F; Branly T; Velot É; Galéra P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628604
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
[TBL] [Abstract][Full Text] [Related]
5. Adeno-Associated Virus-Mediated Overexpression of Interleukin-10 Affects the Immunomodulatory Properties of Equine Bone Marrow-Derived Mesenchymal Stem Cells.
Cameron AD; Even KM; Linardi RL; Berglund AK; Schnabel LV; Engiles JB; Ortved KF
Hum Gene Ther; 2021 Sep; 32(17-18):907-918. PubMed ID: 33843261
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors.
Saldaña L; Bensiamar F; Vallés G; Mancebo FJ; García-Rey E; Vilaboa N
Stem Cell Res Ther; 2019 Feb; 10(1):58. PubMed ID: 30760316
[TBL] [Abstract][Full Text] [Related]
8. Equine osteoarthritis: Strategies to enhance mesenchymal stromal cell-based acellular therapies.
Jammes M; Contentin R; Cassé F; Galéra P
Front Vet Sci; 2023; 10():1115774. PubMed ID: 36846261
[TBL] [Abstract][Full Text] [Related]
9. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
10. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
11. Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy.
Burnham AJ; Foppiani EM; Goss KL; Jang-Milligan F; Kamalakar A; Bradley H; Goudy SL; Trochez CM; Dominici M; Daley-Bauer L; Gibson G; Horwitz EM
Cytotherapy; 2023 Dec; 25(12):1277-1284. PubMed ID: 37815775
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.
Branly T; Contentin R; Desancé M; Jacquel T; Bertoni L; Jacquet S; Mallein-Gerin F; Denoix JM; Audigié F; Demoor M; Galéra P
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389887
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of secretome derived from mesenchymal stem cells with stigmasterol to negate IL-1β-induced inflammation in-vitro using rat chondrocytes-OA management.
Sampath SJP; Rath SN; Kotikalapudi N; Venkatesan V
Inflammopharmacology; 2021 Dec; 29(6):1701-1717. PubMed ID: 34546477
[TBL] [Abstract][Full Text] [Related]
14. Marine Collagen Hydrolysates Downregulate the Synthesis of Pro-Catabolic and Pro-Inflammatory Markers of Osteoarthritis and Favor Collagen Production and Metabolic Activity in Equine Articular Chondrocyte Organoids.
Bourdon B; Contentin R; Cassé F; Maspimby C; Oddoux S; Noël A; Legendre F; Gruchy N; Galéra P
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430111
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the functional heterogeneity of cytokine-primed human umbilical cord mesenchymal stem cells through single-cell RNA sequencing.
Hu Z; Li D; Wu S; Pei K; Fu Z; Yang Y; Huang Y; Yang J; Liu C; Hu J; Cai C; Liao Y
Cell Biosci; 2024 Mar; 14(1):40. PubMed ID: 38532459
[TBL] [Abstract][Full Text] [Related]
16. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Gosálvez J; Roy R; Zaragoza P; Martín-Burriel I; Rodellar C
Stem Cells Dev; 2017 Jan; 26(1):15-24. PubMed ID: 27712399
[TBL] [Abstract][Full Text] [Related]
17. Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment.
Gabner S; Ertl R; Velde K; Renner M; Jenner F; Egerbacher M; Hlavaty J
J Gene Med; 2018 May; 20(5):e3021. PubMed ID: 29608232
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture.
van Buul GM; Villafuertes E; Bos PK; Waarsing JH; Kops N; Narcisi R; Weinans H; Verhaar JA; Bernsen MR; van Osch GJ
Osteoarthritis Cartilage; 2012 Oct; 20(10):1186-96. PubMed ID: 22771777
[TBL] [Abstract][Full Text] [Related]
19. Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis.
Barrachina L; Remacha AR; Romero A; Vitoria A; Albareda J; Prades M; Roca M; Zaragoza P; Vázquez FJ; Rodellar C
BMC Vet Res; 2018 Aug; 14(1):241. PubMed ID: 30119668
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory stimuli differentially modulate the transcription of paracrine signaling molecules of equine bone marrow multipotent mesenchymal stromal cells.
Vézina Audette R; Lavoie-Lamoureux A; Lavoie JP; Laverty S
Osteoarthritis Cartilage; 2013 Aug; 21(8):1116-24. PubMed ID: 23685224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
